Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agents.
D000818:Animals; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D007372:Interferons / Q000096:biosynthesis*; D008297:Male; D008574:Mengovirus / Q000502:physiology; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D010105:Oxygenases / Q000378:metabolism*; D010567:Pertussis Vaccine / Q000494:pharmacology; D011070:Poly I-C / Q000494:pharmacology; D011796:Quinacrine / Q000494:pharmacology; D012313:RNA / Q000502:physiology; D051381:Rats; D013994:Tilorone / Q000494:pharmacology
D010567:Pertussis Vaccine; D012313:RNA; D007372:Interferons; D003577:Cytochrome P-450 Enzyme System; D010105:Oxygenases; D011796:Quinacrine; D013994:Tilorone; D011070:Poly I-C